Medical marijuana may still be far off on the federal level. (iStockPhoto)
DPA Statement: Feds Are Creating a Catch-22 For Research and Policy
NEW YORK–(ENEWSPF)–January 22, 2013. On Tuesday, January 22, 2013, the U.S. Court of Appeals for the District of Columbia Circuit ruled in a case challenging the Drug Enforcement Administration’s designation of marijuana as a Schedule I substance. The court was to decide whether the DEA followed its own rules when making…
